Otezla and Sprintec drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Otezla (apremilast) and Sprintec (ethinyl estradiol; norgestimate). Common drug interactions include nausea among females and psoriasis among males.

The phase IV clinical study analyzes what interactions people have when they take Otezla and Sprintec. It is created by eHealthMe based on reports of 70 people who take the same drugs from the FDA, and is updated regularly.

What is Otezla?

Otezla has active ingredients of apremilast. It is often used in psoriatic arthritis. eHealthMe is studying from 146,254 Otezla users. Check the latest studies of Otezla.

What is Sprintec?

Sprintec has active ingredients of ethinyl estradiol; norgestimate. It is often used in birth control. eHealthMe is studying from 4,397 Sprintec users. Check the latest studies of Sprintec.



On Jul, 21, 2026

70 people who take Otezla and Sprintec together, and have interactions are studied.

Otezla and Sprintec drug interactions.

What are the common drug interactions of Otezla and Sprintec, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  3. Rash
  4. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  5. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  6. Arthralgia (joint pain)
  7. Back pain
  8. Drug ineffective
  9. Tension headache
  10. Burning sensation

male:

  1. Psoriasis (immune-mediated disease that affects the skin)

What are the common drug interactions of Otezla and Sprintec, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Abdominal discomfort
  2. Frequent bowel movements

20-29:

  1. Headache (pain in head)
  2. Nausea (feeling of having an urge to vomit)
  3. Psoriasis (immune-mediated disease that affects the skin)
  4. Abdominal discomfort
  5. Abdominal pain upper
  6. Diarrhoea
  7. Erythema (redness of the skin)
  8. Skin irritation

30-39:

  1. Nausea (feeling of having an urge to vomit)
  2. Vomiting
  3. Psoriasis (immune-mediated disease that affects the skin)
  4. Abdominal discomfort
  5. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  6. Sinusitis (inflammation of sinus)
  7. Arthralgia (joint pain)
  8. Back pain
  9. Diarrhoea
  10. Headache (pain in head)

40-49:

  1. Psoriasis (immune-mediated disease that affects the skin)
  2. Nausea (feeling of having an urge to vomit)
  3. Pruritus (severe itching of the skin)
  4. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  5. Headache (pain in head)
  6. Rash
  7. Infection
  8. Muscle spasms (muscle contraction)
  9. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  10. Joint effusion (presence of extra fluid in joint covering)

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Psoriasis (immune-mediated disease that affects the skin): 50 people, 71.43%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 8 people, 11.43%
  3. Immunodeficiency Common Variable: 5 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Otezla and Sprintec?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Otezla and Sprintec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Otezla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sprintec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Otezla and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sprintec and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on apremilast and ethinyl estradiol; norgestimate (the active ingredients of Otezla and Sprintec, respectively), and Otezla and Sprintec (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: